Renal Cell Carcinoma

VOTRIENT® (pazopanib) for Renal Cell Carcinoma

This slideshow reviews drug information for VOTRIENT® (pazopanib) for renal cell carcinoma. Table of Contents Slide 3: Indication, Dosage, and AdministrationSlide 6: Use in Specific PopulationsSlide 8: Clinical PharmacologySlide 12: Warnings and PrecautionsSlide 19: Clinical Safety and EfficacySlide 23: Drug Storage and Supply

Next post in Renal Cell Carcinoma